IHI Fact Sheet: iShares U.S. Medical Devices ETF
Share
$55.38
close, Nov 20, 2026
Over the year to Nov 19, 2026, IHI returned −9.1% in total and charged 0.37% a year.
- 1-year total return
- −9.0%
- to Nov 20, 2026
- Expense ratio
- 0.37%
- a year
- Net assets
- $3.9bn
- on Nov 19, 2026
- Net flow, last 4 trading days
- −$11.5m
- daily basis to Nov 18, 2026
Growth of $10,000, 1 year
IHI $9,093 −9.1% · Total return, distributions reinvested, Nov 19, 2025 to Nov 19, 2026.
Returns
WindowTotal return
1 month+3.7%
3 months−1.3%
Year to date−10.6%
1 year−9.0%
3 years+13.0%
5 years−12.4%
Total return, distributions reinvested, each window to Nov 20, 2026.
Ten largest positions
HoldingWeight
ABBOTT LABORATORIES17.17%
INTUITIVE SURGICAL13.75%
MEDTRONIC PLC11.77%
IDEXX LABORATORIES5.56%
EDWARDS LIFESCIENCES5.00%
BECTON DICKINSON & COMPANY4.91%
GE HEALTHCARE TECHNOLOGIES4.76%
STRYKER4.72%
RESMED4.40%
BOSTON SCIENTIFIC3.97%
IHI top ten by weight, 76.0% of the fund, of its 51 equity positions, from the holdings published by its issuer for Nov 19, 2026.
Facts
Holds 51 stocks in therapeutics and medical devices, 88% of its weight in S&P 500 companies · First traded May 5, 2006 · Benchmark Its own holdings, as of Nov 19, 2026